AXCELIS TECHNOLOGIES INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 4. Mine Safety Disclosures
Not applicable.
Part II
Our common stock trades on the Nasdaq Global Select Market under the symbol ACLS. As of February 23, 2025, we had approximately 668 stockholders of record.
The following table summarizes the stock repurchase activity for the 12 months ended December 31, 2024 pursuant to our stock repurchase program:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · Total Number of Shares Purchased · Average Price Paid per Share · Total Number of Shares Purchased as Part of Publicly Announced Program · Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program · | ||||||||||
| · · (in thousands except per share amounts) · | ||||||||||
| January 1 through January 31 | | 60 | | $124.72 | | 60 | | $182,523 | | |
| February 1 through February 29 | | 62 | | $121.31 | | 62 | | | 175,007 | |
| March 1 through March 31 | | — | | | | — | | | 175,007 | |
| April 1 through April 30 | | 78 | | $103.33 | | 78 | | | 166,999 | |
| May 1 through May 31 | | 63 | | $110.03 | | 63 | | | 160,011 | |
| June 1 through June 30 | | — | | | | — | | | 160,011 | |
| July 1 through July 31 | | 70 | | $137.48 | | 70 | | | 150,387 | |
| August 1 through August 31 | | 48 | | $111.33 | | 48 | | | 145,011 | |
| September 1 through September 30 | | — | | | | — | | | 145,011 | |
| October 1 through October 31 | | 104 | | $96.23 | | 104 | | | 135,003 | |
| November 1 through November 30 | | 59 | | $85.37 | | 59 | | | 130,012 | |
| December 1 through December 31 | | — | | | | — | | $130,012 | | |
| Total | | 544 | | | | 544 | | | | |
| | | | | | | | | | | |
We currently maintain one equity compensation plan, the 2012 Equity Incentive Plan (the “2012 Equity Plan”). The number of shares issuable upon vesting of outstanding restricted stock units granted to employees and non-employee directors, as well as the number of shares remaining available for future issuance, under the 2012 Equity Plan and our 2020 Employee Stock Purchase Plan as of December 31, 2024 are summarized in the following table:
| · · · · · | |||
|---|---|---|---|
| | (A) | (B) | (C) |
| Plan category · · · Number of shares to be issued upon exercise of outstanding options, warrants and rights (1) · Weighted‑average exercise price of outstanding options, warrants and rights (2) · Number of shares remaining available for future issuance under equity compensation plans (excluding shares reflected in column (A)) (3) | |||
| Equity compensation plans approved by stockholders | 464,904 | $ - | 1,299,342 |
| Equity compensation plans not approved by stockholders | — | N/A | N/A |
| Total | 464,904 | | 1,299,342 |
| | | | |
| (1) Represents 464,904 shares issuable on vesting of outstanding RSUs under the 2012 Equity Plan (some of which will be withheld in respect of tax withholding obligations). | |||
| (2) For the purposes of this table, the weighted-average exercise price of outstanding options, warrants and rights includes RSUs as if they had a $0.00 exercise price. | |||
| (3) Represents the total shares available for issuance under our 2012 Equity Plan and our 2020 Employee Stock Purchase Plan, as of December 31, 2024, as follows: | |||
| (A) | 419,955 shares were available for future issuance under the 2012 Equity Plan. Such amount represents the total number of shares reserved for issuance under the 2012 Equity Plan ((7,762,500 shares approved by the shareholders, plus 1,777,029 shares added in accordance with the terms of the 2012 Equity Plan as a result of the expiration or forfeiture of awards granted under our prior equity grant plan that were outstanding at the time of the adoption of the 2012 Equity Plan), less the shares issuable on options and restricted stock units (counted at 1.5 shares each) outstanding under the 2012 Equity Plan included in column (A)) and the shares issued prior to such date on exercise of options and vesting of restricted stock units granted under the 2012 Equity Plan. This plan is generally used for grants to employees and directors and was initially approved by our stockholders at our 2012 annual meeting. | ||
| (B) | 879,387 shares were available under our 2020 Employee Stock Purchase Plan, which represents the total number of shares reserved for issuance under the plan (1,000,000) less the shares purchased through December 31, 2024. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.